, Tracking Stock Market Picks
Enter Symbol:
Dyax Corp. (DYAX) [hlAlert]

up 608.90 %

Dyax Corp. (DYAX) rated Buy by Morgan Joseph

Posted on: Thursday,  Jan 31, 2008  12:25 PM ET by Morgan Joseph

Morgan Joseph rated Buy Dyax Corp. (NASDAQ: DYAX) on 01/31/2008, when the stock price was $3.37. Since
then, Dyax Corp. has gained 608.90% as of 11/05/2015's recent price of $23.89.
If you would have followed this Morgan Joseph's recommendation on DYAX, you would have gained 608.9% of your investment in 2835 days.

Dyax Corp is a biopharmaceutical company that has developed and patented a method that is used to identify a broad range of compounds with potential for the treatment and diagnosis of diseases. The company is also using this method to identify compounds that could be used in purifying andmanufacturing biopharmaceuticals and other chemicals. The company's phage display technology to rapidly and cost-effectively determine the potential medical uses of newly discovered proteins and genes and subsequently discover biopharmaceutical product candidates.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/31/2008 12:25 PM Buy
as of 12/24/2008
1 Week up  3.98 %
1 Month down  -18.67 %
3 Months down  -25.08 %
1 YTD down  -42.58 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy